Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 10Other 2Breast 2Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Overweight 2Obesity 2Endometrial Neoplasms 2Neoplasms 1Infertility 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 9Methods 8Educational Status 8Exercise 6Early Intervention, Educational 6Interviews as Topic 5Counseling 5semaglutide 3Surveys and Questionnaires 3Standard of Care 3Resistance Training 3Radiotherapy 3Nutrition Assessment 3naldemedine 2Transcutaneous Electric Nerve Stimulation 2Specimen Handling 2Progestins 2Mouthwashes 2Mindfulness 2Megestrol Acetate 2Letrozole 2Health Promotion 2Exercise Test 2Echocardiography 2Drug Therapy 2Diet Therapy 2Bupropion 2mirabegron 1ma zi ren wan 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Megestrol Acetate × Other × 1 year × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡